| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |